Scroll to learn more
Oncology
We are focused on finding answers that transform the way cancers are treated.
We leverage our deep understanding of human biology and cutting-edge research technologies to find new ways to improve the lives of people with cancer. Our scientific discoveries have made a big impact in the treatment of blood cancer, and now we're expanding our knowledge to investigate solid tumors.
Immunology
We work to help people living with chronic, progressive diseases in rheumatology, dermatology and gastroenterology live full lives without limits from their disease.
We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and seek to offer solutions for more diverse patient populations.
Neuroscience
We are dedicated to delivering science that brings us closer to making a significant impact for people living with neurological and psychiatric disorders.
Our neuroscience pipeline consists of innovative, investigational medicines, including symptomatic treatments, disease-modifying approaches, therapeutic toxins and other cutting-edge strategies to address brain disorders.
Aesthetics
Our team is focused on creating products and technologies that advance aesthetic medicine.
Our aesthetics research and development team is investigating the signs of aging and their underlying causes to discover and accelerate comprehensive, scienced-based solutions that enhance people's lives.
Eye Care
Our portfolio and pipeline of new discoveries seek to protect vision and prevent blindness.
Our robust research and development approach is anchored in improving the standards of care for challenging eye diseases to make a meaningful difference for patients.
Other Specialties
Our researchers study a diverse set of diseases with high unmet needs where we believe great progress for patients is possible.
AbbVie’s research extends beyond its core therapeutic areas. We're leveraging our global expertise, innovative technologies, and collaborative approach to drive impactful new discoveries for patients facing these challenging conditions.